Literature DB >> 11484423

Detection time of drugs of abuse in urine.

M Vandevenne1, H Vandenbussche, A Verstraete.   

Abstract

Estimating the detection time of a drug in urine is complex because of many different influencing factors and the lack of experimental data. Detection times vary depending on dose and route of administration, metabolism and characteristics of the screening and confirmation assays. Using a cut-off value of 1000 ng/mL, urinary samples can be positive for amphetamine for up to 5 days after intake of the drug. At the lower 300 ng/mL cut-off, amphetamine will be detectable one day longer. Very few data are available for designer amphetamines. After smoking one marijuana cigarette, THCCOOH (9-carboxy-delta 9 tetrahydrocannabinol) is detectable (using a screening cut-off of 50 ng/mL) for 2-4 days. More frequent use will be detectable for almost 1 month, exceptionally 3 months. Immunoassays to detect cocaine are targeted against the metabolite benzoylecgonine and use a cut-off of 300 ng/mL. An intravenous dose of 20 mg cocaine can be detected for 1.5 days. Street doses (administered via different routes) are detectable up to 1 week, and extremely high doses up to 3 weeks. Heroin rapidly metabolizes to 6-acetylmorphine and morphine. Immunoassays for heroin are calibrated with morphine but important cross-reactivity occurs and positive results must be confirmed by GC-MS. Experimental data for total morphine using a cut-off of 300 ng/mL suggest a detection time of 1 to 1.5 days for relatively low doses of heroin (3-12 mg) administered via i.v., IN or i.m. route.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11484423     DOI: 10.1080/17843286.2000.11754319

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  20 in total

1.  Interdependent group contingency management for cocaine-dependent methadone maintenance patients.

Authors:  Kimberly C Kirby; Marylouise E Kerwin; Carolyn M Carpenedo; Beth J Rosenwasser; Robert S Gardner
Journal:  J Appl Behav Anal       Date:  2008

2.  Pharmacokinetic interaction of enrofloxacin/trimethoprim combination following single-dose intraperitoneal and oral administration in rats.

Authors:  Myung-Jin Choi; Sileshi Belew Yohannes; Seung-Jin Lee; Dereje Damte; Jong-Choon Kim; Joo-Won Suh; Seung-Chun Park
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2013-06-08       Impact factor: 2.441

3.  Shifted balance of dorsal versus ventral striatal communication with frontal reward and regulatory regions in cannabis-dependent males.

Authors:  Feng Zhou; Kaeli Zimmermann; Fei Xin; Dirk Scheele; Wolfgang Dau; Markus Banger; Bernd Weber; René Hurlemann; Keith M Kendrick; Benjamin Becker
Journal:  Hum Brain Mapp       Date:  2018-09-12       Impact factor: 5.038

4.  Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.

Authors:  Joseph Carpenter; Brian Patrick Murray; Sukhshant Atti; Tim P Moran; Arthur Yancey; Brent Morgan
Journal:  J Med Toxicol       Date:  2019-08-30

5.  Utility of Point-of-care Urine Drug Tests in the Treatment of Primary Care Patients With Drug Use Disorders.

Authors:  Michael G McDonell; Meredith C Graves; Imara I West; Richard K Ries; Dennis M Donovan; Kristin Bumgardner; Antoinette Krupski; Chris Dunn; Charles Maynard; David C Atkins; Peter Roy-Byrne
Journal:  J Addict Med       Date:  2016 May-Jun       Impact factor: 3.702

6.  Drug violations and aviation accidents: findings from the US mandatory drug testing programs.

Authors:  Guohua Li; Susan P Baker; Qi Zhao; Joanne E Brady; Barbara H Lang; George W Rebok; Charles DiMaggio
Journal:  Addiction       Date:  2011-04-07       Impact factor: 6.526

Review 7.  Cerebrovascular complications of alcohol and sympathomimetic drug abuse.

Authors:  Askiel Bruno
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

8.  Simultaneous liquid chromatography-mass spectrometry quantification of urinary opiates, cocaine, and metabolites in opiate-dependent pregnant women in methadone-maintenance treatment.

Authors:  Diaa M Shakleya; Riet Dams; Robin E Choo; Hendree Jones; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2010 Jan-Feb       Impact factor: 3.367

9.  Mechanisms of Action and Pharmacokinetics of Cannabis.

Authors:  Sirichai Chayasirisobhon
Journal:  Perm J       Date:  2020-12

10.  Cannabis use while trying to conceive: a prospective cohort study evaluating associations with fecundability, live birth and pregnancy loss.

Authors:  S L Mumford; K S Flannagan; J G Radoc; L A Sjaarda; J R Zolton; T D Metz; T C Plowden; N J Perkins; E A DeVilbiss; V C Andriessen; Purdue-Smithe A C; K Kim; S F Yisahak; J R Freeman; Z Alkhalaf; R M Silver; E F Schisterman
Journal:  Hum Reprod       Date:  2021-04-20       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.